ArticleFrontiers in endocrinology2026
Lactate dehydrogenase A exhibits sorbitol/fructose-related catalytic activity and contributes to polyol pathway metabolism in tumor cells.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cancer cells undergo metabolic reprogramming to support survival under stress conditions. Although the polyol pathway has been extensively studied in diabetes, its role in tumor metabolism remains incompletely understood. This study investigated whether lactate dehydrogenase A (LDHA), a key glycolytic enzyme, contributes to hypoxia-associated sorbitol/fructose metabolism in U87MG tumor cells with relatively low sorbitol dehydrogenase (SDH) expression. Methods: Intracellular metabolites in normoxic and hypoxic U87MG cells were analyzed by mass spectrometry. Recombinant SDH and LDHA were expressed in Escherichia coli, purified, and subjected to comparative kinetic analysis at 25°C and 37°C. LDHA knockdown and overexpression were performed to evaluate intracellular sorbitol and fructose levels, ROS accumulation, and cell viability under hypoxia. Results: Metabolomic analysis showed marked fructose accumulation in hypoxic U87MG cells. Both recombinant SDH and LDHA catalyzed sorbitol oxidation and fructose reduction in vitro, and LDHA showed measurable catalytic turnover at 37°C. Cellular analysis showed that LDHA was readily detectable and increased under hypoxia, whereas SDH remained relatively low. LDHA knockdown reduced intracellular fructose levels, increased sorbitol accumulation, elevated ROS levels, and decreased cell viability under hypoxia, whereas LDHA overexpression showed the opposite trend. Discussion: These findings provide biochemical and cellular evidence that LDHA contributes to hypoxia-associated sorbitol/fructose metabolism and links this metabolic activity to redox balance and cell viability in U87MG cells.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.